Latest Ratios: P/E Ratio 22.9x · EV/EBITDA 15.1x · ROE 21.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $48.0B | $41.4B | $35.4B | $30.6B | $25.3B | $25.6B | $22.7B | $23.9B | $22.4B | $19.5B | $12.1B |
| Enterprise Value | $59.8B | $51.7B | $45.2B | $40.6B | $35.9B | $37.3B | $28.4B | $30.0B | $27.7B | $24.9B | $18.2B |
| P/E Ratio → | 22.89 | 22.18 | 24.94 | 18.34 | 16.81 | 26.01 | 45.72 | 21.93 | 23.88 | 30.19 | 20.93 |
| P/S Ratio | 2.09 | 2.06 | 1.73 | 1.67 | 1.46 | 1.86 | 2.14 | 1.99 | 1.88 | 1.88 | 1.26 |
| P/B Ratio | 5.14 | 4.98 | 3.94 | 3.84 | 3.40 | 3.55 | 3.77 | 3.88 | 3.41 | 2.91 | 1.87 |
| P/FCF | 21.55 | 21.23 | 15.60 | 14.36 | 10.88 | 14.46 | 21.00 | 19.68 | 19.27 | 20.56 | 18.10 |
| P/OCF | 15.74 | 15.50 | 11.57 | 10.92 | 8.64 | 12.07 | 15.25 | 13.16 | 12.57 | 13.57 | 10.16 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.57 | 2.21 | 2.22 | 2.07 | 2.71 | 2.68 | 2.50 | 2.33 | 2.40 | 1.90 |
| EV / EBITDA | 15.07 | 14.89 | 14.74 | 14.16 | 12.36 | 16.66 | 20.00 | 13.10 | 12.90 | 13.51 | 10.79 |
| EV / EBIT | 20.25 | 20.00 | 19.31 | 17.26 | 16.65 | 21.71 | 23.85 | 18.84 | 20.70 | 19.18 | 21.12 |
| EV / FCF | — | 26.52 | 19.90 | 19.03 | 15.40 | 21.09 | 26.24 | 24.72 | 23.87 | 26.30 | 27.31 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.9% | 34.9% | 35.6% | 36.8% | 35.9% | 37.0% | 35.2% | 37.6% | 38.2% | 38.2% | 38.3% |
| Operating Margin | 12.9% | 12.9% | 10.4% | 12.8% | 12.0% | 11.0% | 7.7% | 13.8% | 13.6% | 13.3% | 13.6% |
| Net Profit Margin | 9.3% | 9.3% | 6.9% | 9.1% | 8.7% | 7.1% | 4.7% | 9.1% | 7.9% | 6.2% | 6.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.6% | 21.6% | 16.7% | 21.6% | 20.6% | 14.8% | 8.2% | 17.1% | 14.2% | 9.8% | 15.5% |
| ROA | 6.1% | 6.1% | 4.7% | 5.7% | 5.2% | 4.1% | 2.6% | 5.9% | 5.2% | 3.5% | 4.4% |
| ROIC | 10.4% | 10.4% | 8.7% | 9.8% | 8.5% | 7.4% | 5.1% | 10.3% | 10.1% | 8.4% | 11.3% |
| ROCE | 11.4% | 11.4% | 9.5% | 10.6% | 9.3% | 8.0% | 5.5% | 11.4% | 11.0% | 9.3% | 12.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.35 | 1.35 | 1.26 | 1.43 | 1.60 | 1.82 | 1.19 | 1.04 | 0.86 | 0.86 | 1.00 |
| Debt / EBITDA | 3.23 | 3.23 | 3.70 | 3.97 | 4.10 | 5.87 | 5.06 | 2.81 | 2.62 | 3.12 | 3.81 |
| Net Debt / Equity | — | 1.24 | 1.09 | 1.25 | 1.41 | 1.63 | 0.94 | 0.99 | 0.81 | 0.81 | 0.95 |
| Net Debt / EBITDA | 2.97 | 2.97 | 3.19 | 3.48 | 3.63 | 5.24 | 3.99 | 2.67 | 2.49 | 2.95 | 3.64 |
| Debt / FCF | — | 5.29 | 4.30 | 4.68 | 4.52 | 6.64 | 5.23 | 5.04 | 4.60 | 5.74 | 9.22 |
| Interest Coverage | 8.79 | 8.79 | 8.81 | 14.44 | 15.92 | 9.91 | 4.95 | 12.05 | 12.08 | 9.82 | 8.98 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.80 | 0.80 | 0.81 | 0.91 | 0.89 | 0.95 | 0.98 | 0.75 | 0.79 | 1.01 | 0.91 |
| Quick Ratio | 0.60 | 0.60 | 0.62 | 0.72 | 0.71 | 0.76 | 0.82 | 0.58 | 0.61 | 0.81 | 0.73 |
| Cash Ratio | 0.13 | 0.13 | 0.21 | 0.27 | 0.22 | 0.24 | 0.37 | 0.08 | 0.08 | 0.12 | 0.10 |
| Asset Turnover | — | 0.67 | 0.66 | 0.63 | 0.59 | 0.47 | 0.55 | 0.64 | 0.65 | 0.57 | 0.52 |
| Inventory Turnover | 8.46 | 8.46 | 8.18 | 8.54 | 8.04 | 7.44 | 10.09 | 10.33 | 10.60 | 9.88 | 8.78 |
| Days Sales Outstanding | — | 50.87 | 51.17 | 53.25 | 56.92 | 64.92 | 54.68 | 58.09 | 54.10 | 67.83 | 77.58 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.1% | 2.2% | 2.6% | 2.7% | 3.0% | 2.5% | 1.7% | 2.4% | 2.3% | 2.5% | 1.7% |
| Payout Ratio | 47.7% | 47.7% | 64.2% | 50.4% | 50.6% | 65.0% | 77.5% | 52.8% | 54.7% | 75.7% | 35.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.4% | 4.5% | 4.0% | 5.5% | 5.9% | 3.8% | 2.2% | 4.6% | 4.2% | 3.3% | 4.8% |
| FCF Yield | 4.6% | 4.7% | 6.4% | 7.0% | 9.2% | 6.9% | 4.8% | 5.1% | 5.2% | 4.9% | 5.5% |
| Buyback Yield | 2.4% | 2.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% | 4.2% | 2.2% | 0.0% | 24.7% |
| Total Shareholder Yield | 4.5% | 4.6% | 2.6% | 2.7% | 3.0% | 2.5% | 2.3% | 6.6% | 4.5% | 2.5% | 26.4% |
| Shares Outstanding | — | $456M | $461M | $459M | $458M | $457M | $456M | $469M | $488M | $489M | $385M |
Input cost and volume volatility
According to current market data, CCEP trades at a forward P/E of 22.85, which appears elevated relative to its recent revenue contraction and suggests that investors are pricing in a recovery that may not be supported by the current 0.72 PEG ratio.
The valuation premium relative to peers like KDP suggests the market is assigning significant value to the company's exclusive bottling rights and geographic diversification. However, the disconnect between the forward P/E and the recent deceleration in top-line growth warrants caution, as it implies an expectation of margin expansion that may be difficult to achieve given the structural incidence pricing model.
Based on reported figures, CCEP's ROIC has remained stagnant near 5.4% in 2025Q4, indicating that the company is struggling to generate returns that meaningfully exceed its cost of capital following the large-scale integration of the Asia-Pacific bottling operations.
The persistent low-single-digit ROIC suggests that the capital-intensive nature of the bottling business, combined with the ongoing need for investment in cold-drink equipment, acts as a drag on compounding returns. Investors should monitor whether management can improve asset utilization in the API region to drive a structural shift in these returns over the medium term.
As indicated by the latest financial statements, CCEP's cash conversion cycle has shifted significantly, with a reported -151 days in 2025Q4, reflecting the company's ability to leverage its scale to delay payments to suppliers while maintaining tight control over inventory turnover.
While the negative cash conversion cycle is a hallmark of a powerful distributor, the extreme variance in DPO and DSO suggests that working capital management is highly sensitive to seasonal procurement cycles. This efficiency provides a necessary liquidity buffer, but it may mask underlying operational pressures if the company is forced to extend payment terms to maintain its competitive position with retailers.
Based on the provided quarterly data, CCEP's current ratio has declined to 0.80, which, as reported in recent filings, indicates that current liabilities now exceed current assets and leaves the firm with a limited margin of safety for unexpected operational shocks.
The downward trend in the quick ratio to 0.60 suggests that the company is increasingly reliant on inventory turnover to meet its short-term obligations. This liquidity profile warrants close monitoring, as any disruption in the 'away-from-home' channel could rapidly constrain the company's ability to service its debt without tapping into external credit facilities.
The most commonly misapplied metric for CCEP is the P/E ratio, which fails to account for the 'incidence pricing' model that structurally caps gross margins and obscures the true operational leverage inherent in the company's franchised business model.
Analysts often treat CCEP as a standard consumer staple, but the reliance on concentrate pricing means that revenue growth is often a pass-through of input costs rather than true value creation. A more appropriate metric would be EV/EBITDA adjusted for marketing support payments, which better reflects the cash-generating capacity of the underlying distribution infrastructure.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CCEP stock.
Coca-Cola Europacific Partners PLC's current P/E ratio is 22.9x. The historical average is 36.0x. This places it at the 48th percentile of its historical range.
Coca-Cola Europacific Partners PLC's current EV/EBITDA is 15.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.2x.
Coca-Cola Europacific Partners PLC's return on equity (ROE) is 21.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 13.1%.
Based on historical data, Coca-Cola Europacific Partners PLC is trading at a P/E of 22.9x. This is at the 48th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Coca-Cola Europacific Partners PLC's current dividend yield is 2.09% with a payout ratio of 47.7%.
Coca-Cola Europacific Partners PLC has 34.9% gross margin and 12.9% operating margin. Operating margin between 10-20% is typical for established companies.
Coca-Cola Europacific Partners PLC's Debt/EBITDA ratio is 3.2x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.